Attached files
file | filename |
---|---|
S-1/A - S-1/A - SUPERNUS PHARMACEUTICALS, INC. | a2207731zs-1a.htm |
EX-10.12 - EX-10.12 - SUPERNUS PHARMACEUTICALS, INC. | a2207731zex-10_12.htm |
EX-10.10 - EX-10.10 - SUPERNUS PHARMACEUTICALS, INC. | a2207731zex-10_10.htm |
EX-10.11 - EX-10.11 - SUPERNUS PHARMACEUTICALS, INC. | a2207731zex-10_11.htm |
EX-10.14 - EX-10.14 - SUPERNUS PHARMACEUTICALS, INC. | a2207731zex-10_14.htm |
EX-10.13 - EX-10.13 - SUPERNUS PHARMACEUTICALS, INC. | a2207731zex-10_13.htm |
EX-10.23 - EX-10.23 - SUPERNUS PHARMACEUTICALS, INC. | a2207731zex-10_23.htm |
EX-10.15 - EX-10.15 - SUPERNUS PHARMACEUTICALS, INC. | a2207731zex-10_15.htm |
EX-10.22 - EX-10.22 - SUPERNUS PHARMACEUTICALS, INC. | a2207731zex-10_22.htm |
EX-10.21 - EX-10.21 - SUPERNUS PHARMACEUTICALS, INC. | a2207731zex-10_21.htm |
EX-4.1 - EX-4.1 - SUPERNUS PHARMACEUTICALS, INC. | a2207731zex-4_1.htm |
EX-10.24 - EX-10.24 - SUPERNUS PHARMACEUTICALS, INC. | a2207731zex-10_24.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption Experts and to the use of our report dated March 15, 2012, in Amendment No. 4 to the Registration Statement (Form S-1 No. 333-171375) and related Prospectus of Supernus Pharmaceuticals, Inc. for the registration of shares of its common stock.
|
/s/ Ernst & Young LLP |
|
|
McLean, Virginia |
|
March 15, 2012 |
|